Clinical Trial 40239


Long Beach, CA 90806

Study Summary:

Open-label Study of Safety and Tolerability of Chronic
Intermittent Usage for 24 or 52 Weeks of Intranasal
Dihydroergotamine Mesylate (DHE) Administered using
the I123 Precision Olfactory Delivery (POD®) Device
[INP104, POD-DHE] in Patients with Migraine Headache

Qualified Participants Must:

• Adult males and females, 18 to 65 years of age
• Must have documented diagnosis of migraine

Qualified Participants May Receive:

Compensation for time and travel 

Study is Available At:

CNS Network
2600 Redondo Ave.
Long Beach, CA 90806
View Clinic Location


If you or someone you care for is interested in participating in this clinical trial and lives within 50 miles of the clinic, please complete the form below and click 'I Am Interested In This Study'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.